FFIV
50
4
INTU
63
9
MAR
68
-3
IR
55
-11
HAS
66
2
OXY
38
-2
WFC
69
-5
LB
31
-2
NVDA
49
3
MCHP
55
5
AMT
25
-5
LMT
55
-4
EIX
58
4
ACN
52
-4
AMZN
52
4
DTE
40
4
EOG
36
-9
PFE
41
12
MRK
60
2
ABBV
46
-4
FFIV
50
4
INTU
63
9
MAR
68
-3
IR
55
-11
HAS
66
2
OXY
38
-2
WFC
69
-5
LB
31
-2
NVDA
49
3
MCHP
55
5
AMT
25
-5
LMT
55
-4
EIX
58
4
ACN
52
-4
AMZN
52
4
DTE
40
4
EOG
36
-9
PFE
41
12
MRK
60
2
ABBV
46
-4
Financhill
Back

RBC Quant EAFE Dividend Leaders ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison

Buy
66

RID.TO
RBC Quant EAFE Dividend Leaders ETF

Last Price:
$34.89
Seasonality Move:
-2.4%
Sell
42

CRSP
CRISPR Therapeutics AG

Last Price:
$55.85
Seasonality Move:
14.46%
Buy
66
RBC Quant EAFE Dividend Leaders ETF (RID.TO) is a Buy

Is RBC Quant EAFE Dividend Leaders ETF a Buy, Sell or Hold?

  • The current RBC Quant EAFE Dividend Leaders ETF [RID.TO] share price is $34.65. The Score for RID.TO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • RID.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $54.84. The Score for CRSP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RID.TO Stock Price Chart

What is RBC Quant EAFE Dividend Leaders ETF's stock price today?

  • The RBC Quant EAFE Dividend Leaders ETF share price today is $34.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RID.TO is experiencing slight buying pressure.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $54.84
    The current trend is relatively stagnant and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

RID.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.89 Buy
Relative Strength Index (14 RSI): 57.46 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.68 - 34.66) Buy
Bollinger Bands (100): (31.98 - 34.12) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 45.78 Sell
Chaikin Money Flow: -1252802 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.68 - 56.94) Buy
Bollinger Bands (100): (52.47 - 65.41) Sell

RID.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.56 Buy
20-day SMA: 34.34 Buy
50-day SMA: 33.88 Buy
200-day SMA: 31.26 Buy
8-day EMA: 13.66 Buy
20-day EMA: 6.27 Buy
50-day EMA: 2.66 Buy
200-day EMA: 0.68 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.4 Sell
20-day SMA: 54.72 Buy
50-day SMA: 59.34 Sell
200-day SMA: 51.04 Buy
8-day EMA: 55.77 Sell
20-day EMA: 55.78 Sell
50-day EMA: 56.38 Sell
200-day EMA: 37.38 Buy

RBC Quant EAFE Dividend Leaders ETF Earnings Growth & RID.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

RBC Quant EAFE Dividend Leaders ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):